Literature DB >> 17295757

Non-alcoholic fatty liver disease: further expression of the metabolic syndrome.

Giovanni Tarantino1, Gennaro Saldalamacchia, Paolo Conca, Adriano Arena.   

Abstract

Non-alcoholic fatty liver disease has been associated with metabolic disorders, including central obesity, dyslipidemia, hypertension and hyperglycemia. Metabolic syndrome, obesity, and insulin resistance are major risk factors in the pathogenesis of non-alcoholic fatty liver disease. Non-alcoholic fatty liver disease refers to a wide spectrum of liver damage, ranging from simple steatosis to non-alcoholic steatohepatitis, advanced fibrosis and cirrhosis.

Entities:  

Mesh:

Year:  2007        PMID: 17295757     DOI: 10.1111/j.1440-1746.2007.04824.x

Source DB:  PubMed          Journal:  J Gastroenterol Hepatol        ISSN: 0815-9319            Impact factor:   4.029


  64 in total

Review 1.  Spleen: A new role for an old player?

Authors:  Giovanni Tarantino; Silvia Savastano; Domenico Capone; Annamaria Colao
Journal:  World J Gastroenterol       Date:  2011-09-07       Impact factor: 5.742

Review 2.  Recent advances in dietary supplementation, in treating non-alcoholic fatty liver disease.

Authors:  Tannaz Eslamparast; Sareh Eghtesad; Hossein Poustchi; Azita Hekmatdoost
Journal:  World J Hepatol       Date:  2015-02-27

3.  High prevalence of nonalcoholic fatty liver in patients with idiopathic venous thromboembolism.

Authors:  Matteo Nicola Dario Di Minno; Antonella Tufano; Anna Rusolillo; Giovanni Di Minno; Giovanni Tarantino
Journal:  World J Gastroenterol       Date:  2010-12-28       Impact factor: 5.742

4.  Thymic NF-κB-inducing kinase regulates CD4+ T cell-elicited liver injury and fibrosis in mice.

Authors:  Hong Shen; Liang Sheng; Yi Xiong; Yeung-Hyen Kim; Lin Jiang; Zheng Chen; Yong Liu; Kalyani Pyaram; Cheong-Hee Chang; Liangyou Rui
Journal:  J Hepatol       Date:  2017-03-06       Impact factor: 25.083

Review 5.  Exposure to ambient air particulate matter and non-alcoholic fatty liver disease.

Authors:  Giovanni Tarantino; Domenico Capone; Carmine Finelli
Journal:  World J Gastroenterol       Date:  2013-07-07       Impact factor: 5.742

6.  Biochemical parameters response to weight loss in patients with non-alcoholic steatohepatitis.

Authors:  Shehab M Abd El-Kader; Fadwa M Al-Shreef; Osama H Al-Jiffri
Journal:  Afr Health Sci       Date:  2016-03       Impact factor: 0.927

Review 7.  What is the role of adiponectin in obesity related non-alcoholic fatty liver disease?

Authors:  Carmine Finelli; Giovanni Tarantino
Journal:  World J Gastroenterol       Date:  2013-02-14       Impact factor: 5.742

8.  Risk factors and mechanisms of non-alcoholic steatohepatitis.

Authors:  Chantal A Rivera
Journal:  Pathophysiology       Date:  2008-07-29

9.  Synergistic effect of fatty liver and smoking on metabolic syndrome.

Authors:  Po-Hsin Chiang; Tsui-Yen Chang; Jong-Dar Chen
Journal:  World J Gastroenterol       Date:  2009-11-14       Impact factor: 5.742

10.  Toll-like receptor-2 deficiency enhances non-alcoholic steatohepatitis.

Authors:  Chantal A Rivera; LaTausha Gaskin; Monique Allman; Jia Pang; Kristen Brady; Patrick Adegboyega; Kevin Pruitt
Journal:  BMC Gastroenterol       Date:  2010-05-28       Impact factor: 3.067

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.